Richard Harris appears in the following:
Monday, December 05, 2016
A gene-editing technology called CRISPR-cas9 could be a gold mine for its inventors, but it's not clear who owns the idea. U.S. patent judges will soon hear oral arguments to decide the issue.
Tuesday, November 29, 2016
The House could vote Wednesday on a vast bill that stretches nearly a thousand pages and holds changes large and small for the National Institutes of Health and the Food and Drug Administration.
Monday, November 28, 2016
There's a plethora of projects to gather data about the brain, various kinds of cancer and every type of cell in the body. But researchers are struggling to keep up with the information explosion.
Monday, November 28, 2016
Medical researchers are no longer ignoring the people who have the most to gain — or lose. But as patient advocates become more influential, they risk being co-opted by the biomedical industry.
Tuesday, November 15, 2016
The federal government spends more than $30 billion a year to fund the National Institutes of Health. How will a new administration affect academic research? What about pharmaceutical research?
Sunday, November 13, 2016
People with unlucky genes but good health habits were half as likely to develop heart disease as those who had an unhealthful lifestyle and genes that increased their heart risk, a study found.
Thursday, November 10, 2016
The Centers for Disease Control and Prevention says smoking rates have fallen from 21 percent of the adult population in 2005 to 15 percent in 2015, when the agency conducted its latest survey.
Monday, November 07, 2016
Scientists are racing to create a vaccine. The latest effort being tested uses inactivated virus, a technique that has been used successfully to fight other diseases, and human volunteers.
Sunday, November 06, 2016
Up until he retired as head of the National Academy of Sciences, the soft-spoken atmospheric scientist spent his career diligently directing a skeptical public to the human causes of climate change.
Friday, November 04, 2016
Candida auris has infected hospitalized patients with weakened immune systems or other serious conditions. Four of the seven patients died, but it's unclear if the fungus was the cause.
Tuesday, October 25, 2016
Fifty patients with Lou Gehrig's disease have volunteered for a study of a dietary supplement as an experimental treatment. Even a failure could help by eliminating a dead end from consideration.
Thursday, October 20, 2016
Blood clots are on the list of conditions that doctors are supposed to consider when figuring out unexplained fainting spells. An Italian study suggests physicians should be more alert to clots.
Wednesday, October 19, 2016
Pfizer is poised to start selling Inflectra, its version of the blockbuster rheumatoid arthritis drug Remicade. But the price of Inflectra is only 15 percent less.
Wednesday, October 12, 2016
Researchers often combine the results of many medical studies to evaluate treatments. But when the combiners have a financial interest, the results might be inaccurate, a scientist says.
Wednesday, October 05, 2016
The 2016 Nobel for chemistry goes to Jean-Pierre Sauvage, Sir J. Fraser Stoddart and Bernard L. Feringa. The chemists are French, Scottish and Dutch, respectively.
Thursday, September 29, 2016
Just as natural antibodies help your body find and fight microbial invaders, tailored research antibodies let scientists target and study cancer cells. But too many are poorly made, scientists say.
Saturday, September 24, 2016
The Food and Drug Administration approved a muscular dystrophy drug despite deeply flawed evidence. Was the decision a dangerous precedent or flexible pragmatism reflecting patients' values?
Friday, September 23, 2016
In the past 50 years, better medical care and healthier habits have greatly reduced the risk of dying young from heart disease. But the obesity epidemic threatens to reverse that happy trend.
Friday, September 16, 2016
The aim is to make clinical trial data available to volunteers and scientists, even if a drug or therapy being tested turns out to be a failure. That could help identify serious side effects.
Thursday, September 15, 2016
The Trump campaign released information about the candidate's health Thursday. It shows normal test results.